Imamura Masaru 今村勝

… Alternative Names

IMAMURA MASARU 今村勝

IMAMURA Masaru 今村勝

Less

Researcher Number	80464006
Other IDs
Affiliation (Current)	2025: 新潟大学, 医歯学系, 准教授
Affiliation (based on the past Project Information) *help	2020 – 2024: 新潟大学, 医歯学総合病院, 講師 2023: 新潟大学, 医歯学総合病院, 准教授 2016 – 2018: 新潟大学, 医歯学総合病院, 講師 2015: 新潟大学, 医歯学系, 助教 2012: 新潟大学, 医歯学総合病院, 特任助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Pediatrics Except Principal Investigator Pediatrics / Basic Section 52050:Embryonic medicine and pediatrics-related
Keywords	Principal Investigator 細胞療法 / CAR-NK / CAR / 腫瘍免疫 / 免疫細胞療法 / GD2 / 神経芽腫 / NK細胞増幅 / 膜結合型キメラサイトカイン / NK細胞療法 … More / NK細胞 / 膜結合型サイトカイン / 免疫チェックポイント分子 / T細胞療法 / Programmed cell death-1 / キメラ抗原受容体 … More Except Principal Investigator NK細胞 / NKp44 / NK細胞受容体 / CAR-T細胞 / キメラ抗原受容体 / 細胞療法 / 小児がん / 脳腫瘍 / 肉腫 / メモリー様NK細胞 / CAR-NK細胞 / childhood cancer / cytotoxic T cell / 遺伝子改変リンパ球 / 白血病 / 難治がん / Natural killer cell / solid tumor / sarcoma / cancer immunotherapy / CAR / がん免疫療法 / CD4^+T細胞 / CD4^+ T細胞 / B細胞性腫瘍 / キメラ型受容体 / CD28 / 4-1BB / CD19 / 臍帯血移植 / 難治性白血病 / chimeric receptor Less

難治性神経芽腫に対する新規NK細胞療法の開発Principal Investigator
- Principal Investigator
  
  今村勝
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Niigata University
メモリー様分化誘導を基盤とした多種類のがんに有効なCAR-NK細胞製剤の新規開発
- Principal Investigator
  
  今井千速
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  University of Toyama
  Niigata University
Novel CAR-NK cell therapies that are safe, effective and can be used by anyone at any timePrincipal Investigator
- Principal Investigator
  
  Masaru Imamura
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Niigata University
Development of NK Cell expansion by a novel membrane-bound chimeric cytokinePrincipal Investigator
- Principal Investigator
  
  Imamura Masaru
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Niigata University
Development of Novel Immunotherapy of Cancer: NKp44-based Chimeric Antigen Receptors and Methods for Ex Vivo NK cell Expansion
- Principal Investigator
  
  Imai Chihaya
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pediatrics
- Research Institution
  Niigata University
Development of a novel chimeric antigen receptor T cell immunotherapy targeting immune checkpoint moleculesPrincipal Investigator
- Principal Investigator
  
  IMAMURA Masaru
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pediatrics
- Research Institution
  Niigata University
Translational Research on the Use of Genetically Modified HumanNatural Killer Cells for Refractory Leukemia.
- Principal Investigator
  
  IMAI Chihaya
- Project Period (FY)
  2009 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pediatrics
- Research Institution
  Niigata University

All 2024 2023 2022 2018 2017 2016 2013 2012 2011 Other

All Journal Article Presentation Other

[Journal Article] Regression of kaposiform lymphangiomatosis and chronic disseminated intravascular coagulation after inhaled budesonide‐formoterol treatment2024
- Author(s)
  Imamura Masaru、Shin Chansu、Ozeki Michio、Matsuoka Kentaro、Saitoh Akihiko、Imai Chihaya
- Journal Title
  
  Pediatric Blood and Cancer
  
  Volume: 71 Issue: 4
- DOI
  10.1002/pbc.30907
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K24297
[Journal Article] Isolated salivary gland extramedullary relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia during blinatumomab treatment2024
- Author(s)
  Kawakami Yugo、Imamura Masaru、Imai Chihaya
- Journal Title
  
  International Journal of Hematology
  
  Volume: 119 Issue: 5 Pages: 479-480
- DOI
  10.1007/s12185-024-03756-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K24297
[Journal Article] Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features.2024
- Author(s)
  Satake D, Natsumeda M, Satomi K, Tada M, Sato T, Okubo N, Kawabe K, Takahashi H, Tsukamoto Y, Okada M, Sano M, Iwabuchi H, Shibata N, Imamura M, Imai C, Takami H, Ichimura K, Nishikawa R, Umezu H, Kakita A, Oishi M.
- Journal Title
  
  Current Oncology
  
  Volume: 31 Issue: 4 Pages: 1831-1838
- DOI
  10.3390/curroncol31040138
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K06951, KAKENHI-PROJECT-23K24297
[Journal Article] NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma2023
- Author(s)
  Yudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, Chansu Shin, Masaru Imamura, Naoki Oike, Takashi Ariizumi, Akihiko Saitoh, Minori Baba, Tomohiro Miyazaki, Yuko Suzuki, Yiwei Ling, Shujiro Okuda, Keichiro Mihara, Akira Ogose, Hiroyuki Kawashima, Chihaya Imai
- Journal Title
  
  Transl Oncol
  
  Volume: ahead Pages: 1-1
- DOI
  10.1016/j.tranon.2022.101521
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K17850, KAKENHI-PROJECT-23K24297
[Journal Article] Newly diagnosed ETV6-RUNX1?positive B-acute lymphoblastic leukemia localized to the left pelvic bone marrow2022
- Author(s)
  Baba Minori、Imamura Masaru、Imai Chihaya
- Journal Title
  
  International Journal of Hematology
  
  Volume: 115 Issue: 2 Pages: 151-152
- DOI
  10.1007/s12185-021-03269-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08317, KAKENHI-PROJECT-23K24297
[Journal Article] Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin2022
- Author(s)
  Nakata Satoshi、Murai Junko、Okada Masayasu,,,,,Tateishi Kensuke、Yamashita Shinji、Eberhart Charles G、Natsumeda Manabu
- Journal Title
  
  Neuro-Oncology
  
  Volume: 25 Issue: 5 Pages: 899-912
- DOI
  10.1093/neuonc/noac243
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K09210, KAKENHI-PROJECT-22K16679, KAKENHI-PROJECT-21KK0156, KAKENHI-PROJECT-20K15919, KAKENHI-PROJECT-23K24297, KAKENHI-PROJECT-22K20953, KAKENHI-PROJECT-21H03042
[Journal Article] BRAFV600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis.2022
- Author(s)
  Ko Kudo, Tsutomu Toki, Rika Kanezaki, and Etsuro Ito
- Journal Title
  
  Haematologica
  
  Volume: epub ahead Issue: 7 Pages: 000-000
- DOI
  10.3324/haematol.2021.279857
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07813, KAKENHI-PROJECT-21K06909, KAKENHI-PROJECT-21K06938, KAKENHI-PROJECT-20K07442, KAKENHI-PROJECT-23K21429, KAKENHI-PROJECT-23K24297
[Journal Article] Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child2017
- Author(s)
  Iwabuchi H, Kawashima H, Umezu H, Takachi T, Imamura M, Saitoh A, Ogose A, Imai C.
- Journal Title
  
  Int J Hematol.
  
  Volume: 106 Issue: 2 Pages: 299-303
- DOI
  10.1007/s12185-017-2202-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10015
[Journal Article] 軟部組織病変を呈し特異な臨床経過を示したランゲルハンス細胞組織球症の1例．2017
- Author(s)
  古寺一樹, 今村勝, 高地貴行, 申将守, 笠原靖史, 岩渕晴子, 川島寛之, 生越章, 梅津哉, 齋藤昭彦, 今井千速．
- Journal Title
  
  日本小児血液・がん学会雑誌．
  
  Volume: 54 Pages: 157-160
- NAID
  130005960310
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10015
[Journal Article] Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan2016
- Author(s)
  Imamura T, Kiyokawa N, Kato M, Imai C, Okamoto Y, Yano M, Ohki K, Yamashita Y, Kodama Y, Saito A, Mori M, Ishimaru S, Deguchi T, Hashii Y, Shimomura Y, Hori T, Kato K, Goto H, Ogawa C, Koh K, Taki T, Manabe A, Sato A, Kikuta A, Adachi S, Horibe K, Ohara A, Watanabe A, Kawano Y, Ishii E, Shimada H
- Journal Title
  
  Blood Cancer J
  
  Volume: 6 Issue: 5 Pages: e419-e419
- DOI
  10.1038/bcj.2016.28
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K09486, KAKENHI-PROJECT-16K10015
[Journal Article] Alveolar rhabdomyosarcoma after treatment of osteosarcoma2013
- Author(s)
  Kasahara Y, Iwabuchi H, Takachi T, Hosokai R, Yoshida S, Imamura M, Watanabe A, Umezu H, Hotta T, Ogose A and Imai C
- Journal Title
  
  Pediatrics International
  
  Volume: 未定
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591349
[Journal Article] 家系に複数の脾臓摘出者を認め遺伝性球状赤血球症と考えられていたHb Koeln症の一例2012
- Author(s)
  笠原靖史、細貝亮介、高地貴行、吉田咲子、今村勝、今井千速．
- Journal Title
  
  日本小児血液・がん学会雑誌
  
  Volume: 49 Pages: 138-141
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591349
[Journal Article] Disseminated BCG Infection Mimicking Metastatic Nasopharyngeal Carcinoma in anImmunodeficient Child with a Novel Hypomorphic NEMO Mutation2011
- Author(s)
  Imamura M, Takachi T, Yoshida S, Imai C
- Journal Title
  
  J Clin Immunol
  
  Volume: 31 Issue: 5 Pages: 802-10
- DOI
  10.1007/s10875-011-9568-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591349
[Journal Article] Lymphoblastic lymphoma with mature B-cell immunophenotype and MLL-AF9 in a child2011
- Author(s)
  Takachi T, Iwabuchi H, Imamura M, Imai C
- Journal Title
  
  Pediatr Blood Cancer
  
  Volume: 57 Issue: 7 Pages: 1251-1252
- DOI
  10.1002/pbc.23228
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591349
[Presentation] Generation of chimeric antigen receptor-transduced natural killer cells by using a feeder cell-free system2022
- Author(s)
  Nobuhiro Kubo, Minori Baba, Chansu Shin, Ryosuke Hosokai, Haruko Iwabuchi, Masaru Imamura, Akihiko Saitoh, Chihaya Imai
- Organizer
  第84回日本血液学会
- Data Source
  KAKENHI-PROJECT-23K24297
[Presentation] SJMB-96 based high-dose chemotherapy and CSI within 2 weeks after surgery for medulloblastoma; A Case Series from a Single-Center2022
- Author(s)
  Imamura Masaru, Baba Minori, Kubo Nobuhiro, Shin Changsu, Kasahara Yasushi, Hosokai Ryosuke, Iwabuchi Haruko, Oishi Makoto, Ishikawa Hiroyuki, Imai Chihaya
- Organizer
  第64回日本小児血液・がん学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24297
[Presentation] Development of novel chimeric antigen receptor targeting PD-1 ligands in cancer cells.2018
- Author(s)
  Chansu Shin, Nobuhiro Kubo, Yasushi Kasahara, Haruko Iwabuchi, Masaru Imamura, Akihiko Saitoh, Chihaya Imai
- Organizer
  第80回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-16K10015
[Presentation] Development of CAR-T therapy using NKp44 ectodomain for antigen recognition2018
- Author(s)
  笠原靖史、久保暢大、申将守、岩渕晴子、今村勝、今井千速
- Organizer
  第10回血液疾患免疫療法学会学術集会
- Data Source
  KAKENHI-PROJECT-16K10015
[Presentation] Development of novel chimeric antigen receptor targeting PD-1 ligands in Osteosarcoma.2018
- Author(s)
  Chansu Shin, Nobuhiro Kubo, Yasushi Kasahara, Haruko Iwabuchi, Masaru Imamura, Akihiko Saitoh, Chihaya Imai
- Organizer
  50th annual congress of the international society of paediatric oncology
- Data Source
  KAKENHI-PROJECT-16K10015
[Presentation] Superior Activity of NKp44-CAR-T Cells in Comparison with Ex Vivo Expanded Activated NK cells or NKp30-CAR-T cells2018
- Author(s)
  笠原靖史、申将守、久保暢大、岩渕晴子、今村勝、齋藤昭彦、今井千速
- Organizer
  第60回日本小児血液・がん学会学術集会
- Data Source
  KAKENHI-PROJECT-16K10015
[Presentation] NKp44キメラ抗原受容体による新しいがん免疫治療の開発2018
- Author(s)
  笠原靖史、久保暢大、申将守、高地貴行、岩渕晴子、今村勝、今井千速
- Organizer
  第228回日本小児科学会新潟地方会
- Data Source
  KAKENHI-PROJECT-16K10015
[Presentation] PD-1 ligands are upregulated after T-cell attack in childhood solid tumors and may become a candidate for CAR-T cell therapy.2018
- Author(s)
  Chansu Shin, Nobuhiro Kubo, Yasushi Kasahara, Haruko Iwabuchi, Masaru Imamura, Akihiko Saitoh, Chihaya Imai
- Organizer
  第60回日本小児血液・がん学会学術集会
- Data Source
  KAKENHI-PROJECT-16K10015
[]

1. IMAI Chihaya (90419284)

# of Collaborated Projects: 6 results

# of Collaborated Products: 17 results
2. TAKACHI Takayuki (70444164)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
3. SAKIKO Yoshida (30535183)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
4. IWABUCHI Haruko (60444163)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 三原圭一朗 (90363077)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 久保貴紀 (90435751)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
7. TATEISHI Kensuke

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 滝智彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 工藤耕

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
10. 土岐力

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
11. 凌一葦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
12. 高見浩数

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 里見介史

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Imamura Masaru 今村 勝

IMAMURA MASARU 今村 勝

IMAMURA Masaru 今村 勝

Research Projects

Research Products

Co-Researchers

難治性神経芽腫に対する新規NK細胞療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

メモリー様分化誘導を基盤とした多種類のがんに有効なCAR-NK細胞製剤の新規開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Novel CAR-NK cell therapies that are safe, effective and can be used by anyone at any timePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of NK Cell expansion by a novel membrane-bound chimeric cytokinePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Novel Immunotherapy of Cancer: NKp44-based Chimeric Antigen Receptors and Methods for Ex Vivo NK cell Expansion

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of a novel chimeric antigen receptor T cell immunotherapy targeting immune checkpoint moleculesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Translational Research on the Use of Genetically Modified HumanNatural Killer Cells for Refractory Leukemia.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Regression of kaposiform lymphangiomatosis and chronic disseminated intravascular coagulation after inhaled budesonide‐formoterol treatment2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Isolated salivary gland extramedullary relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia during blinatumomab treatment2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features.2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Newly diagnosed ETV6-RUNX1?positive B-acute lymphoblastic leukemia localized to the left pelvic bone marrow2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] BRAFV600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis.2022

Author(s)

Imamura Masaru 今村勝

IMAMURA MASARU 今村勝

IMAMURA Masaru 今村勝